A case of Argyria: Multiple forms of silver ingestion in a patient with comorbid schizoaffective disorder

Cutis

Volumn 89, Issue 5, 2012, Pages 221-224

  Schrauben, Sarah J ^a   Bhanusali, Dhaval G ^a   Sheets, Stuart ^a   Sinha, Animesh A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILVER DERIVATIVE;

ALTERNATIVE MEDICINE; ARGYRIA; ARTICLE; CASE REPORT; COLLOID; FACE; HUMAN; MALE; MIDDLE AGED; NECK; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PSYCHOSIS;

ARGYRIA; COLLOIDS; COMPLEMENTARY THERAPIES; DIABETES MELLITUS, TYPE 2; FACE; HUMANS; MALE; MIDDLE AGED; NECK; PSYCHOTIC DISORDERS; SILVER COMPOUNDS;

EID: 84864089358     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wadhera A, Fung M. Systemic argyria associated with ingestion of colloidal silver. Dermatol Online J. 2005;11:12.
2. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). final rule. Fed Regist. 1999;64:44653-44658.
3. Lai MW, Ewald MB. Silver. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies. 8th ed. New York, NY: McGraw-Hill; 2006: 1358-1363.
4. Fung MC, Bowen DL. Silver products for medical indications: risk-benefit assessment. J Toxicol Clin Toxicol. 1996;34:119-126.
5. Osol A, Farrar GE Jr. The Dispensary of the United States of America. 25th ed. Philadelphia, PA: Lippincott, 1960.
6. Demling RH, Leslie DeSanti MD. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. Burns. 2002;28:264-266.
7. US Environmental Protection Agency. Silver (CASRN 7440-22-4). http://www.epa.gov/iris/subst/0099.htm. Revised December 1, 1996. Accessed April 10, 2012.
8. Hill WR, Pillsbury DM. Argyria, the Pharmacology of Silver. 1st ed. Baltimore, MD: The Williams and Wilkins Co; 1939.
9. Gaul LE, Staud AH. Clinical spectroscopy. seventy cases of generalized argyrosis following organic and colloidal silver medication, including a biospectrometric analysis of ten cases. J Am Med Assoc. 1935;104:1387-1390.
10. Jänner M, Marschelke I, Voigt H. Localized intramural silver impregnation of the tongue. differential diagnosis from malignant melanoma [in German]. Hautarzt. 1980;31:510-512.
11. Rusch-Behrend GD, Gutmann JL. Management of diffuse tissue argyria subsequent to endodontic therapy: report of a case. Quintessence Int. 1995;26:553-557.
12. Farmer ER, Hood AF. Pathology of the Skin. 2nd ed. New York, NY: McGraw-Hill Health Professions Division; 2000.
13. Wan AT, Conyers RA, Coombs CJ, et al. Determination of silver in blood, urine, and tissue of volunteers and burn patients. Clin Chem. 1991;37(10, pt 1):1683-1687.
14. Haddad LM, Winchester JF, eds. Clinical Management of Poisoning and Drug Overdose. 2nd ed. Philadelphia, PA: Saunders; 1990.
15. Jurecka W. Generalized argyrosis. Hautarzt. 1986;37:628-631.
16. Padlewska KK, Schwartz RA. Argyria. Emedicine [serial online]. http://emedicine.medscape.com/article/1069121-overview. Updated August 15, 2011. Accessed April 16, 2012.
17. Rhee DY, Chang SE, Lee MW, et al. Treatment of argyria after colloidal silver ingestion using Q-switched 1,064-nm Nd:YAG laser. Dermatol Surg. 2008;34:1427-1430.
18. Anderson EL, Janofsky J, Jayaram G. Argyria as a result of somatic delusions. Am J Psychiatry. 2008;165:649-650.
19. Rungby J, Danscher G. Hypoactivity in silver exposed mice. Acta Pharmacol Toxicol (Copenh). 1984;55:398-401.
20. Ohbo Y, Fukuzako H, Takeuchi K, et al. Argyria and convulsive seizures caused by ingestion of silver in a patient with schizophrenia. Psychiatry Clin Neurosci. 1996;50:89-90.